Literature DB >> 23454132

Synthesis and discovery of novel piperidone-grafted mono- and bis-spirooxindole-hexahydropyrrolizines as potent cholinesterase inhibitors.

Yalda Kia1, Hasnah Osman, Raju Suresh Kumar, Vikneswaran Murugaiyah, Alireza Basiri, Subbu Perumal, Habibah A Wahab, Choi Sy Bing.   

Abstract

Three-component reaction of a series of 1-acryloyl-3,5-bisbenzylidenepiperidin-4-ones with isatin and L-proline in 1:1:1 and 1:2:2 molar ratios in methanol afforded, respectively the piperidone-grafted novel mono- and bisspiro heterocyclic hybrids comprising functionalized piperidine, pyrrolizine and oxindole ring systems in good yields. The in vitro evaluation of cholinesterase enzymes inhibitory activity of these cycloadducts disclosed that monospiripyrrolizines (8a-k), are more active with IC50 ranging from 3.36 to 20.07 μM than either the dipolarophiles (5a-k) or bisspiropyrrolizines (9a-k). The compounds, 8i and 8e with IC50 values of 3.36 and 3.50 μM, respectively showed the maximum inhibition of acethylcholinesterase (AChE) and butrylylcholinestrase (BuChE). Molecular modeling simulation, disclosed the binding interactions of the most active compounds to the active site residues of their respective enzymes. The docking results were in accordance with the IC50 values obtained from in vitro cholinesterase assay.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23454132     DOI: 10.1016/j.bmc.2013.01.066

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  A green, multicomponent, regio- and stereo-selective 1,3-dipolar cycloaddition of azides and azomethine ylides generated in situ with bifunctional dipolarophiles using PEG-400.

Authors:  Jayant Sindhu; Harjinder Singh; J M Khurana
Journal:  Mol Divers       Date:  2014-02-28       Impact factor: 2.943

2.  Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.

Authors:  Ilandari Dewage Udara Anulal Premachandra; Kevin A Scott; Chengtian Shen; Fuqiang Wang; Shelley Lane; Haoping Liu; David L Van Vranken
Journal:  ChemMedChem       Date:  2015-08-12       Impact factor: 3.466

3.  Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2'-pyrrolidine-3',3''-pyrrolidines].

Authors:  M Adel Youssef; Siva S Panda; Riham A El-Shiekh; ElSayed M Shalaby; Dalia R Aboshouk; Walid Fayad; Nehmedo G Fawzy; Adel S Girgis
Journal:  RSC Adv       Date:  2020-06-08       Impact factor: 4.036

4.  Synthesis of a New Class of Spirooxindole-Benzo[b]Thiophene-Based Molecules as Acetylcholinesterase Inhibitors.

Authors:  Assem Barakat; Saeed Alshahrani; Abdullah Mohammed Al-Majid; M Ali; Mezna Saleh Altowyan; Mohammad Shahidul Islam; Abdullah Saleh Alamary; Sajda Ashraf; Zaheer Ul-Haq
Journal:  Molecules       Date:  2020-10-13       Impact factor: 4.411

5.  Tosylhydrazine-promoted self-conjugate reduction-Michael/aldol reaction of 3-phenacylideneoxindoles towards dispirocyclopentanebisoxindole derivatives.

Authors:  Sayan Pramanik; Chhanda Mukhopadhyay
Journal:  Beilstein J Org Chem       Date:  2022-04-27       Impact factor: 2.544

6.  Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties.

Authors:  Nehmedo G Fawazy; Siva S Panda; Ahmed Mostafa; Benson M Kariuki; Mohamed S Bekheit; Yassmin Moatasim; Omnia Kutkat; Walid Fayad; May A El-Manawaty; Ahmed A F Soliman; Riham A El-Shiekh; Aladdin M Srour; Reham F Barghash; Adel S Girgis
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

7.  A facile ionic liquid promoted synthesis, cholinesterase inhibitory activity and molecular modeling study of novel highly functionalized spiropyrrolidines.

Authors:  Abdulrahman I Almansour; Raju Suresh Kumar; Natarajan Arumugam; Alireza Basiri; Yalda Kia; Mohamed Ashraf Ali; Mehvish Farooq; Vikneswaran Murugaiyah
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.